The pathogenesis of asbestos-related lung diseases is complicated and still
poorly understood. Studies on animal models and cell cultures have indicat
ed that asbestos fibres generate reactive oxygen and nitrogen species and c
ause oxidation and/or nitrosylation of proteins and deoxyribonucleic acid a
s a marker of cell injury. These effects are potentiated by the inflammatio
n caused by the fibres. Recent studies have shown that individual variabili
ty in the antioxidant and/or detoxifying mechanisms probably has an importa
nt role in the development of asbestos-related lung diseases. Asbestos fibr
es cause both cell proliferation and apoptosis by multiple mechanisms, one
of them being activation of signal transduction pathways by reactive oxygen
and nitrogen species. Asbestos activates transcription factors such as nuc
lear factor kappa B, which has been shown to lead to the upregulation of an
tioxidant enzymes, most importantly manganese superoxide dismutase. This en
zyme is also overexpressed in asbestos-related human malignant mesothelioma
, whereas the induction of other antioxidant enzymes (copper-zinc superoxid
e dismutase, catalase, glutathione peroxidase) by asbestos fibres appears t
o be marginal. The significance of antioxidant enzymes in asbestos related
diseases has, however, remained unclear. Furthermore, previous studies have
not been able to offer successful therapies to the patients with asbestos-
associated diseases. Only an improved understanding of the pathogenetic mec
hanisms in the human lung provides a basis for future therapies for asbesto
s-related diseases.